EIF2AK2 and neoplasm: At dose levels of both 1 and 5 mg kg−1, the PKR inhibitor effectively attenuated both the depression in body weight (Figure 1A) and tumour growth (Figure 1B), although the time course for these two events appeared to be distinct (Figure 1C).